Editor in chief Joel Dunning spoke with Professor James Tatoulis, a cardiothoracic surgeon at Royal Melbourne Hospital in Melbourne, Australia.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Coronary disease
February 1, 2024
In findings presented at the STS annual meeting, the ten-year data showed the survival benefit of multi- over single-arterial grafting in all but patients who are severely obese. The study used data from the STS Adult Cardiac Surgery Database to look at patients who underwent isolated CABG over a ten-year period.
January 31, 2024
At the 2023 EACTS Annual Meeting, CTSNet Editor in Chief Joel Dunning and CTSNet senior editors set out to interview the most knowledgable CT surgeons from around the world. Stay tuned for more interviews from the meeting.
January 9, 2024
This video presents patch repair of large post-myocardial infarction posterior left ventricular pseudoaneurysm involving the mitral valve apparatus.
December 19, 2023
The technique in this video combines recent positive trends in coronary artery bypass grafting including the use of skeletonized BIMA, no-touch saphenous vein, epiaortic scanning, intraoperative transit time flow measurement, and high-frequency ultrasound assessment.
December 18, 2023
This video demonstrates the short-term safety and efficacy of an emerging operative technique—transconal unroofing of an intraseptal anomalous left coronary artery with patch reconstruction of the right ventricular outflow tract—in a pediatric patient with impaired coronary perfusion.
December 14, 2023
The ISCHEMIA trial has caused heated discussion in the cardiovascular field, with its results being used to downgrade coronary artery bypass grafting (CABG) recommendations in recent guidelines. The authors of this paper performed a detailed re-analysis of the ISCHEMIA trial and critically examined its findings.
December 7, 2023
In this study, the authors performed a propensity matched analysis of hospital costs for robotic-assisted CABG vs. conventional CABG. 1,173 patients were included in the analysis from 2018 until 2021. Decision regarding intervention modality was decided by the treating surgeon.
November 30, 2023
This Novo Nordisk funded, multicenter, double blind, randomized, placebo-controlled trial explored whether semaglutide (a glucagon-like peptide-1 receptor agonist) can reduce cardiovascular risk associated with overweight and obesity in the absence of diabetes.
November 20, 2023
The elderly population is exponentially increasing worldwide, leading to a higher incidence of coronary artery disease. The growing number of elderly patients is closely related to a higher incidence of frailty.